FIELD: pharmaceuticals.
SUBSTANCE: invention refers to hydrogel medicament containing prospidinum, dextrane polymer-phosphates or starch phosphates and water at the next contents of components (g/100 ml): Prospidinum - 5.0 - 10.0. Dextrane phosphate or starch phosphate - 5.0-20.0. Water - up to 100 ml.
EFFECT: invention ensures receipt prolonged medical formula of prospidinum as hydrogels ensuring increase of anticancer action of cytostatic.
1 dwg, 2 dwg, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING GEL-FORMING DEXTRANE PHOSPHATES | 2010 |
|
RU2455007C1 |
GEL-FORMING MIXED DEXTRAN ESTER PHOSPHATES AND CARBAMATES, METHOD FOR PREPARING THEM | 2010 |
|
RU2468804C2 |
PREVENTIVE COMPOSITION BASED ON PHENOLIC SUBSTANCES IN LIPOSOME FORM | 2008 |
|
RU2372929C1 |
PHARMACEUTICAL COMPOSITION OF ANTITUMOR ACTIVITY (VERSIONS) AND METHOD FOR ITS OBTAINING (VERSIONS) | 1999 |
|
RU2201759C2 |
PREVENTIVE COMPOSITION BASED ON SUBSTANCES OF PHENOL NATURE | 2008 |
|
RU2354395C1 |
ANTITUMOR AGENT | 1998 |
|
RU2128042C1 |
ANTITUMOR CHEMICAL PREPARATION | 2016 |
|
RU2629608C1 |
METHOD FOR PHOTODYNAMIC THERAPY OF RAT SURFACE SOLID CONNECTIVE TISSUE SARCOMA M-1 | 2021 |
|
RU2776449C1 |
ANTICANCER DRUG CONTAINING CYTIDINE DERIVATIVE AND CARBOPLATIN | 2009 |
|
RU2482855C2 |
ANTITUMOR AGENT | 1999 |
|
RU2144821C1 |
Authors
Dates
2012-02-20—Published
2010-08-18—Filed